Number of Patients, Male	14
Number of Patients, Female	0
Age	Median: 71 years
Number of Prior Systemic Therapies	None
Performance Status: ECOG	0 — 7 1 — 7 2 — 0 3 — 0 Unknown — 0
Other	Prior therapies: nine of the patients in the enzalutamide‐only arm had prior progression on abiraterone; three of the patients in the enzalutamide‐only arm had prior progression on docetaxel.